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Epstein-Barr virus (EBV) encodes a set of core repli-
cation factors used during lytic infection in human cells
that parallels the factors used in many other systems.
These include a DNA polymerase and its accessory fac-
tor, a helicase/primase, and a single strand binding pro-
tein. The EBV polymerase accessory factor has been
identified as the product of the BMRF1 gene and has
been shown by functional assays to increase the activity
and processivity of the polymerase. Unlike other mem-
bers of this class of factors, BMRF1 is also a transcrip-
tion factor regulating certain EBV genes. Although sev-
eral polymerase accessory factors, including eukaryotic
proliferating cell nuclear antigen, Escherichia coli 
protein, and T4 gene 45 protein have been shown to form
oligomeric rings termed sliding clamps, nothing is
known about the oligomeric state of BMRF1 or whether
it forms a ring. In this work, BMRF1 was purified di-
rectly from human cells infected with an adenovirus
vector expressing the BMRF1 gene product. The protein
was purified to near homogeneity, and examination by
negative staining electron microscopy revealed large,
flat, ring-shaped molecules with a diameter of 15.5  0.8
nm and a distinct 5.3-nm diameter hole in the center.
The size of these rings is consistent with an oligomer of
6 monomers, nearly twice as large as the trimeric pro-
liferating cell nuclear antigen ring. Unlike the herpes
simplex virus UL42 homologue, BMRF1 was found to
self-associate in solution. These findings extend the
theme of polymerase accessory factors adopting ring-
shaped structures and provide an example in which the
ring is significantly larger than any previously de-
scribed sliding clamp.
The human -herpesvirus Epstein-Barr virus (EBV)1 has
both a latent and a lytic replicative cycle. In the latent phase,
the virus is maintained as an episome and replicates using the
OriP origin of replication and cellular machinery (1–4). Lytic
infection uses a separate origin, OriLyt and several virally
encoded proteins (5–7), and is currently believed to occur via a
rolling circle mechanism producing head to tail concatemers
(6). Rolling circle replication would utilize the EBV gene prod-
ucts BALF1 (catalytic component of viral DNA polymerase),
BMRF1 (the polymerase accessory protein), BALF2 (single
strand binding protein), BSLF1 (primase), BBLF4 (helicase),
and BBLF2/3 (helicase/primase-associated protein) (8, 9). Li-
gase and RNase H functions would also be required.
The BMRF1 polymerase accessory factor exists in two phos-
phorylated forms of 50 and 52 kDa, while a third unphospho-
rylated 48-kDa form is seen in baculovirus-infected cells (10).
BMRF1 co-purifies with the 110-kDa EBV DNA polymerase,
and they appear to function together as a holoenzyme (11–13).
Polymerase activity is stimulated by more than 10-fold when
BMRF1 is included in reactions containing the catalytic sub-
unit and an activated DNA template (14). Additionally, BMRF1
appears to increase the processivity of the viral polymerase,
suggesting a model in which the accessory protein acts as a
sliding clamp that prevents dissociation of the polymerase from
the active template. The herpes simplex virus type 1 UL42
polymerase accessory protein does not share extensive amino
acid homology with BMRF1, but in both proteins the amino-
terminal two-thirds of the molecule contains a DNA-binding
domain and a region of interaction with the catalytic subunit
(15). Both BMRF1 and UL42 bind to double strand DNA with
high affinity in contrast to the well characterized sliding
clamps Escherichia coli , T4 gene 45 protein, and PCNA,
which lack an intrinsic DNA-binding activity (16–18). A unique
feature of BMRF1 is that it also serves as a transcriptional
activator, a function that to date has not been found with other
polymerase accessory proteins (19). Transcriptional activation
may function to induce viral proteins that are required for lytic
replication.
E. coli , T4 gene 45 protein, and PCNA have been shown to
form oligomeric rings that can translocate along DNA without
direct contacts that could inhibit polymerase movement (16–
18). Despite the high affinity for DNA, BMRF1 does not appear
to retard the holoenzyme, and this has also been observed with
UL42 (20). PCNA and T4 gene 45 proteins form homotrimers,
whereas E. coli  is a homodimer (21), and the checkpoint
sliding clamp Rad9-Rad1-Hus1 is a heterotrimeric ring (22).
Each of these sliding clamps has a homologous ATP-dependent
clamp loading factor that actively places the clamp around
DNA. Clamp loaders have not been identified for BMRF1 or
UL42. In this study, we used electron microscopy (EM) to
examine the structural organization of BMRF1 in solution. We
find it exists as a ring-shaped structure with a distinct hole in
the center. The size of the rings is suggestive of an oligomer of
6 monomers.
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MATERIALS AND METHODS
Cells and Adenovirus Vectors—A replication-deficient adenovirus
vector (E1/E3 deleted) expressing the BMRF1 protein (AdBMRF1) con-
trolled by the human cytomegalovirus immediate-early promoter was
made using the Cre-lox-mediated recombination systems as described
previously (23). The control vector contained the bacterial -galactosid-
ase gene (AdLacZ) instead of the BMRF1 gene. HeLa cells were infected
with the adenovirus vectors at a multiplicity of infection of 10.
Plasmid Vectors—A vector expressing full-length BMRF1 protein
linked at its amino terminus in-frame with glutathione S-transferase
(GST) was a gift from David Dorsky (University of Connecticut Health
Center). A plasmid containing the BMRF1 gene inserted into the SG5
vector (Stratagene) was used for in vitro translation studies and was a
gift from David Dorsky.
Protein Purification of BMRF1 Expressed in Cells—Adenovirus-in-
fected HeLa cells (10  150-mm plates) were harvested 48 h after
infection. Cells were washed twice with 1 phosphate-buffered saline
(5 ml/plate) and then scraped into 2 ml of phosphate-buffered saline/
plate and pelleted by low speed centrifugation (1000  g for 10 min at
4 °C). Cells were resuspended in 10 ml of lysis buffer (50 mM Tris, pH
7.5, 100 mM NaCl, 0.5 mM MgCl2, 1 mM EDTA, 2 mM dithiothreitol, 0.2%
Nonidet P-40, and 1 mM phenylmethylsulfonyl fluoride) followed by one
freeze-thaw cycle and sonication (three 15-s pulses, 50% duty cycle).
Lysates were clarified by high speed centrifugation at 10,000  g for 40
min at 4 °C. Using a fast protein liquid chromatography system, sam-
ples were applied to a 10-ml heparin-Sepharose (Amersham Bio-
sciences) column pre-equilibrated with Buffer H (20 mM Hepes, pH 7.9,
0.2 mM EDTA, 20% glycerol, 2 mM dithiothreitol, and 0.1 mM phenyl-
methylsulfonyl fluoride) containing 100 mM KCl at a flow rate of 0.1
ml/min. The column was washed with 10 column volumes of Buffer H
plus 100 mM KCl and eluted with a 30-ml gradient of 100–800 mM KCl
in Buffer H. Peak fractions were dialyzed against 4 liters of Buffer H
plus 100 mM KCl and then loaded on a 10-ml DNA-cellulose column
(Amersham Biosciences) pre-equilibrated with Buffer H plus 100 mM
KCl at a flow rate of 0.1 ml/min. The column was washed with Buffer H
plus 100 mM KCl, and proteins were eluted with a 30-ml gradient of
100–800 mM KCl in Buffer H. Peak fractions were dialyzed against
Buffer H containing 100 mM KCl and 20% glycerol prior to storage.
Protein concentrations were determined by Bradford assays.
Western Blot Analysis—Proteins were separated on 10% discontinu-
ous SDS-PAGE followed by immobilization on nitrocellulose mem-
branes using an electrotransfer system (Bio-Rad). Membranes were
blocked with 5% nonfat dried milk in 1 TBS-T (20 mM Tris, pH 7.6,
137 mM NaCl, 0.1% Tween 20) for 1 h at room temperature and incu-
bated with a 1:500 dilution of a mouse monoclonal antibody to BMRF1
(Capricorn, Inc.) in blocking buffer at 4 °C overnight. Blots were washed
three times (10 min/wash) in 1 TBS-T, incubated with a 1:5000
dilution of the secondary antibody, goat anti-mouse conjugated to horse-
radish peroxidase, for 1 h at room temperature, washed three times
with 1 TBS-T, and detected by chemiluminescence (ECL kit, Amer-
sham Biosciences).
BMRF1 Dimerization Assays—35S-Labeled in vitro translated
BMRF1 protein was produced from the SG5-BMRF1 vector using the
TNT-T7 quick-coupled in vitro translation system (Promega). GST or
GST-BMRF1 proteins coupled to 50 l of glutathione beads (50% slurry)
(Sigma) were incubated with 3 l of the 35S-labeled in vitro translated
BMRF1 protein in 500-l reactions containing binding buffer (20 mM
Tris pH 7.9, 75 mM KCl, 25 mM MgCl2, 0.1 mM EDTA, 10 mM dithio-
threitol, 0.15% Nonidet P-40) for 1 h at 4 °C. The beads were washed
five times in binding buffer, and bound proteins were analyzed by 10%
SDS-PAGE and autoradiography.
Electron Microscopy—For negative staining, the protein was diluted
to a concentration of 30–50 g/ml in 20 mM Tris-HCl, pH 7.5, 50 mM
NaCl, and 5 mM MgCl2, adsorbed to a thin carbon foil according to the
method of Valentine and Green (24), and negatively stained with 2%
uranyl acetate. Transmission electron microscopy was performed using
a Philips CM12 electron microscope. The micrographs were recorded at
a 60,000 magnification and scanned using a Nikon LS4500 film scan-
ner. Morphometric measurements were made using Gatan Digital Im-
age software. Images were arranged into panels using Adobe Photo-
Shop software.
RESULTS AND DISCUSSION
Purification of BMRF1 from Cells—Previous studies with
purified BMRF1 have utilized either baculovirus vectors or in
vitro transcription and translation systems to express the pro-
tein. One of the concerns with these systems is whether all of
the post-translational modifications placed on the protein in
infected human cells have been added. For example, BMRF1
purified from baculovirus-infected insect cells is a mixture of
two phosphorylated and one unphosphorylated form (10). To
ensure that the BMRF1 protein used for these studies was as
close as possible to its cellular state, we used an adenovirus-
based vector system to express BMRF1 in HeLa cells. These
have been used to demonstrate that, in vivo, BMRF1 can en-
hance the gastrin gene expression.2 As a control, a vector
containing the bacterial LacZ gene was used. Lysates from
HeLa cells infected with the AdBMRF1 or AdLacZ were pre-
pared 48 h after infection. The expressed proteins were first
passed over a heparin-Sepharose column, and bound proteins
were eluted using a salt gradient. A single peak was observed
by A320 nm measurement, and fractions within this peak were
found to contain BMRF1 by Western blot analysis. Appropriate
fractions were pooled, dialyzed to decrease the salt concentra-
tion, and then applied to a DNA-cellulose column. Proteins
were eluted using a salt gradient, and peak fractions were
tested by Western blot analysis for the presence of BMRF1 (see
under “Materials and Methods”). SDS-PAGE and Western blot
analysis from pooled fractions of both columns are shown in
Fig. 1. As seen in Fig. 1A, pooled fractions from the heparin-
Sepharose and DNA-cellulose columns showed a strong band
around 50 kDa in Coomassie Blue-stained gels. Western blots
analysis revealed two bands in both column pools that presum-
ably represent the 50- and 52-kDa proteins (Fig. 1B). The
BMRF1 band in the heparin-Sepharose fractions was by far the
most dominant species, representing 60% of the total protein,
2 Holley-Guthrie, E. A., Seaman, W. T., Bhende, P., Merchant, J. L.,
and Kenney, S. C. (2004) J. Virol., in press.
FIG. 1. Purification of BMRF1. HeLa cells were infected with Ad-
BMRF1 or AdLacZ and purified by chromatography using heparin-
Sepharose (HS) and DNA-cellulose (DC) columns as described under
“Materials and Methods.” Pooled fractions from both columns were
visualized by Coomassie Blue staining (A) or Western blot analysis (B)
using the anti-BMRF1 antibody.
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with the remaining 40% spread over a wide range of molecular
weights. The DNA-cellulose pool was near homogeneity as de-
termined by Coomassie Blue staining. Parallel purification us-
ing lysates from AdLacZ-infected cells showed negligible
amounts of contaminating protein after the DNA-cellulose
column (Fig. 1).
BMRF1 Interacts with Itself—Although the herpes simplex
virus type 1 DNA polymerase processivity factor UL42 does not
form a dimer (20), the Kaposi sarcoma herpesvirus DNA po-
lymerase processivity factor was recently shown to dimerize
(25), particularly when bound to DNA. To determine whether
BMRF1 can interact with itself, 35S-labeled in vitro translated
BMRF1 protein was incubated with either GST protein or a
GST-BMRF1 conjugated to glutathione-linked beads, and pro-
teins bound to the beads were analyzed by SDS-PAGE and
autoradiography. As shown in Fig. 2, in vitro translated
BMRF1 did not interact with the GST protein alone but clearly
interacted with the GST-BMRF1 fusion protein. Thus, BMRF1
can dimerize and/or form higher order structures with itself in
solution.
Visualization of BMRF1 Rings—To directly examine the oli-
gomeric state of BMRF1, unfixed protein in a buffer containing
50 mM NaCl and 5 mM MgCl2 was prepared for EM by negative
staining with 2% uranyl acetate (see under “Materials and
Methods”). Examination of BMRF1 purified through the DNA-
cellulose column step to homogeneity revealed molecules with a
distinct ring-shaped structure, but the relatively low protein
concentration resulted in the rings being scattered at a dis-
tance in the fields. Efforts to concentrate the sample led to a
loss of the protein. However, when BMRF1 purified only
through the heparin-Sepharose step (which was at a higher
protein concentration) was examined, fields with the same
rings much more closely spaced were observed (Fig. 3A). Al-
though the heparin-Sepharose pool was contaminated with
other proteins, BMRF1 was the predominant protein detected
by Coomassie Blue staining, and the protein concentrations
were high enough for negative staining. The BMRF1 particles
seen in the heparin-Sepharose pool matched the size and
shapes observed in the highly pure DNA-cellulose peak, and
thus we concluded that these rings are indeed formed by
BMRF1. There was no evidence as seen by EM from either
protein pool for a significant concentration of protein particles
of sizes that would correspond to BMRF1 dimers, compact
trimers, or tetramers. Closer examination of the rings showed
that the majority had a very distinct appearance (Fig. 3B).
Analysis of their dimensions revealed a diameter of 15.5  0.8
nm (n  12), with a 5.3  0.8 nm (n  10) hole in the center.
Some particles appeared deformed possibly because of the
staining procedure or interaction with the carbon foil. The only
projection of the BMRF1 ring observed was that of a flat disk
with a large hole, suggesting that the rings are too thin to be
stable lying edgewise on the EM support.
Simple modeling of these structures suggests that the most
probable oligomeric state is that of a ring with six subunits.
The BMRF1 ring appears as a flat toroid constructed of a
5-nm-wide protein tube that forms a smooth contoured ring
15.5  0.8 nm wide with a 5.3  0.8-nm hole in the center. The
molecular weight of streptavidin is close to that of a BMRF1
monomer, and its diameter is 5.6  1.3 nm. Modeling indicates
that six such protein balls could easily be arranged side by side
to generate the rings observed here. Other arrangements and
oligomeric states, however, are possible depending on the
shape of the BMRF1 monomer. Unfortunately, efforts at simple
rotational analysis were not successful, and more complex sin-
gle particle reconstruction will be required in the future to
resolve individual monomers in the rings and obtain a higher
resolution structure.
The Classic Sliding Clamps—E. coli , T4 gene 45 protein, and
eukaryotic PCNA all share a nearly exact “Christmas wreath”-
shaped ring structure (16–18) in spite of being formed from two
(E. coli ) or three (PCNA and T4 gene 45 protein) subunits.
Furthermore, the checkpoint clamp Rad9-Rad1-Hus1 is a hetero-
trimer with a shape similar to the latter proteins consisting of an
8.5-nm-diameter ring with a 3.5-nm hole (22). All of these rings
have molecular masses of approximately 100 kDa. It is not clear
what the significance of a larger ring would be and how this may
be related to its association with the EBV DNA polymerase and
other proteins. Additionally, it is not known how BMRF1 or
UL42 is assembled around DNA in the apparent absence of
ATP-dependent clamp loading factors such as those utilized by
the classic sliding clamps. Possibly the nonspecific affinity of
FIG. 2. BMRF1 associates with itself in solution. Glutathione
beads conjugated with GST or GST-BMRF1 were incubated with 35S-
labeled in vitro translated BMRF1, and proteins immobilized to the
beads were analyzed by SDS-PAGE and autoradiography. Input from
the in vitro translated material was included as control.
FIG. 3. Visualization of BMRF1 by electron microscopy.
BMRF1 was negatively stained with uranyl acetate and adsorbed to a
thin carbon foil as described under “Materials and Methods.” A, a field
of dispersed BMRF1 molecules is shown. Scale bar  20 nm. B, a gallery
of BMRF1 particles at a higher magnification showing ring-like parti-
cles with a diameter of 15.5 nm and a central hole diameter of 5.5 nm.
Scale bar  10 nm.
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BMRF1 and UL42 for duplex DNA allows them to self-assemble
around DNA. Future studies of both proteins assembled onto
DNA may aid in answering such questions.
The multisubunit structures observed by EM are consistent
with the data demonstrating that BMRF1 can associate with
itself in solution. In contrast, UL42 does not form dimers or
other higher order oligomers in solution (20). The polymerase
processivity factor of another -herpesvirus, Kaposi sarcoma
herpesvirus, has been shown to self-associate, and oligomeriza-
tion appears to be required for enhanced polymerase processiv-
ity and DNA binding (25). In this latter study, however, cross-
linking reagents were required to observe oligomerization.
BMRF1 is unique among the polymerase processivity factors
in performing a second function as a transcriptional activator.
BMRF1 activates one of the two EBV OriLyt promoters (the
early viral BHLF1 promoter) as well as the cellular gas-
trin promoter2 (19, 26). The BMRF1-responsive regions of the
BHLF1 and gastrin promoters contain binding sites for the cel-
lular transcription factors SP1 and ZBP-89, although the pre-
cise mechanisms for the BMRF1 transcriptional effect have not
yet been defined. Whether the ring-like structures observed in
this study also mediate the transcriptional effects of BMRF1
remains unknown. It is possible that alternative conformations
or structures of BMRF1 mediate its replication versus tran-
scriptional effects. For example, BMRF1 is hyperphosphoryl-
ated by the virally encoded kinase BGLF4 (27, 28) in infected
cells. Clearly, this hyperphosphorylation is not required for
ring formation, but it may provide a mechanism that could
regulate these structures presumably involved in its polymer-
ase processivity function, as contrasted with possible alterna-
tive conformations that may be needed for the regulation of
transcription.
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